课题基金 / 基金详情

Novel pharmacotherapy for ischemic heart disease with cardioprotective activity of endogenous acetylcholine.

Novel pharmacotherapy for ischemic heart disease with cardioprotective activity of endogenous acetylcholine.
具有内源性乙酰胆碱心脏保护活性的缺血性心脏病的新型药物疗法。
批准号:
21790729
负责人:
ARIKAWA Mikihiko
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2010

项目摘要

项目成果

相关文献

中文摘要
翻译
在本研究中,我们研究了乙酰胆碱酯酶抑制剂多奈哌齐对小鼠心肌梗死(MI)急性期心功能障碍和重构的急性作用。结果表明,多奈哌齐可抑制梗死心肌基质金属蛋白酶-9 (MMP-9)相关的急性炎症组织损伤,从而降低心肌梗死急性期左心室游离壁破裂的风险。
英文摘要
In the present study, we investigated the acute effect of donepezil, an acetylcholinesterase inhibitor, on cardiac dysfunction and remodeling during an acute phase of myocardial infarction (MI) in mice. As results, donepezil inhibited matrix metalloproteinase-9 (MMP-9)-related acute inflammatory tissue injury in the infarcted myocardium, thereby reduced the risk of left ventricular free wall rupture during the acute phase of MI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.yjmcc.2009.11.010
发表时间: 2010-04-01
期刊: JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
影响因子: 5
作者: [Kakinuma, Yoshihiko, Furihata, Mutsuo, Sato, Takayuki]
通讯作者: Sato, Takayuki
DOI: 10.1371/journal.pone.0020629
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者: [Arikawa M, Kakinuma Y, Handa T, Yamasaki F, Sato T]
通讯作者: Sato T
Donepezil : An acetylcholinesterase inhibitor against Alzheimer's dementia, prevents remodeling and improves survival in volume overload heart failure mice.
多奈哌齐:一种针对阿尔茨海默氏痴呆症的乙酰胆碱酯酶抑制剂,可防止容量超负荷心力衰竭小鼠的重塑并提高其存活率。
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [Kuwabara, M, Handa T, Handa T, Handa T]
通讯作者: Handa T
DOI: 10.1016/j.jtcvs.2008.08.020
发表时间: 2009-01-01
期刊: JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
影响因子: 6
作者: [Katare, Rajesh G., Ando, Motonori, Sato, Takayuki]
通讯作者: Sato, Takayuki
14